Should I Buy CGC? CGC 2026 Analysis

Should You Buy Canopy Growth Corp (CGC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.100

1 Day change

1.85%

52 Week Range

2.380

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: trend is still bearish (SMA200 > SMA20 > SMA5) and momentum (MACD histogram) remains below zero.
Price is pushing into near-term resistance (R1 ~1.188) after a small pre-market uptick; risk/reward is unfavorable without a confirmed breakout.
Options positioning is bullishly skewed (very low put/call ratios), but that alone doesn’t outweigh the weak/uncertain fundamental backdrop and negative longer-term technical structure.
No Intellectia “must-buy” triggers today (AI Stock Picker and SwingMax both show no signal), so there’s no proprietary edge to justify chasing an entry ahead of earnings (2026-02-11 pre-market).

Technical Analysis

Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), implying rallies are more likely to be sold.
Momentum: MACD histogram at -0.00291 (below 0) with negative contraction—bearish momentum is easing, but not flipped bullish yet.
RSI: RSI_6 ~56.6 (neutral) — not oversold, so there isn’t a clear “snap-back” buy setup.
Key levels: Pivot 1.142 (important line in the sand). Resistance at R1 1.188 then R2 1.216; support at S1 1.096 then S2 1.068.
Practical read: With price ~1.17, you’re closer to resistance than support; that’s typically a poor entry location for an impatient buyer.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Extremely low put/call ratios (OI PCR 0.09; Volume PCR 0.18) suggests call-heavy/speculative bullish sentiment.
Activity: Today’s option volume is elevated vs typical (today vs 30D avg ~24.56), indicating heightened attention.
Volatility: IV30 ~112.79 vs HV ~88.52 (IV > HV) implies options are pricing large moves; however, IV percentile ~21.6 / IV rank ~25.97 suggests IV is not extreme relative to its own history.
Takeaway: Options traders are leaning bullish, but the underlying chart still hasn’t confirmed a durable reversal—risk of call-chasing into resistance remains high.

Technical Summary

Sell

Buy

Positive Catalysts

- Debt maturity extension to 2031 improves near-term liquidity/financing runway (news 2026-01-29).
- Revenue trend improving (latest quarter shows YoY revenue growth) and some commentary points to operational improvement.
- Pattern-based projection provided suggests modest positive drift probabilities over 1W/1M (model indicates +2.51% next week, +6.65% next month).
- Upcoming earnings (2026-02-11 pre-market) can act as a catalyst if results/guide surprise positively.

Neutral/Negative Catalysts

- News flow remains broadly cautious/negative: “continued struggles” and “dismal outlook” themes (2026-02-02; 2026-01-30).
- Profitability still weak: losses persist, and margins are deteriorating (see latest quarter snapshot).
- Technical backdrop remains bearish (downtrend MAs; MACD below zero), increasing odds of failed rallies.
- Event risk: earnings soon (2026-02-11 pre-market) can create downside gaps if expectations aren’t met.
- No supportive “smart money” signal: hedge funds and insiders are neutral; no notable accumulation signals provided.

Financial Performance

Latest quarter: 2026/Q2.
Revenue: 66.683M, +5.86% YoY (top-line improving).
Net income: -1.639M (down -98.72% YoY) — profitability remains negative.
EPS: -0.01 (down -99.32% YoY) — earnings power still weak.
Gross margin: 32.85%, down -5.25% YoY — margin compression is a key concern even as revenue grows.
Bottom line: Growth is present, but quality of growth is questionable due to continued losses and weaker margins.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Ratings have improved from outright bearish to more neutral.
2025-11-10: Benchmark upgraded to Hold from Sell after “steady operational improvement” and improved liquidity.
2025-12-15: Alliance Global raised PT to C$2.50 (from C$2) while maintaining Neutral, citing the MTL Cannabis acquisition as attractive due to profitability/cash flow positivity.
Wall Street pros: Improving liquidity/operations; strategic acquisition could strengthen supply/quality and cash-flow profile.
Wall Street cons: Still largely a Neutral/Hold view; profitability challenges and execution risk remain; the story is more “stabilization” than “clear growth + profits.”

3 Analyst Rating

Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 3.78 USD with a low forecast of 1.8 USD and a high forecast of 5.76 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 1.080

Low

1.8

Averages

3.78

High

5.76

Current: 1.080

Low

1.8

Averages

3.78

High

5.76

Alliance Global

Aaron Grey

Neutral

downgrade

AI Analysis

2026-02-06

New

Reason

Alliance Global

Aaron Grey

Price Target

AI Analysis

2026-02-06

New

downgrade

Neutral

Reason

Alliance Global analyst Aaron Grey lowered the firm's price target on Canopy Growth to C$1.80 from C$2.50 and keeps a Neutral rating on the shares following the fiscal Q3 report. The firm reduced the stock's multiple to reflect the potential impact from changes to veteran reimbursement and uncertainty around its gross margins.

Alliance Global

Neutral

maintain

2025-12-15

Reason

Alliance Global

Price Target

2025-12-15

maintain

Neutral

Reason

Alliance Global raised the firm's price target on Canopy Growth to C$2.50 from C$2 and keeps a Neutral rating on the shares after the company announced plans to acquire MTL Cannabis in a cash and stock transaction at a total valuation of C$179M. The firm believes the combination of MTL being profitable and cash flow positive, along with providing access to quality indoor cultivation, makes the acquisition attractive, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CGC

Unlock Now

CGC Should I Buy

CGC Should I Buy

Should You Buy Canopy Growth Corp (CGC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch